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Abstract
The Notch signaling cascade is deregulated in diverse cancer types. Specific Notch function in cancer is depen-
dent on the cellular context, the particular homologs expressed, and cross-talk with other signaling pathways. We
have previously shown that components of the Notch signaling pathway are deregulated in meningiomas. How-
ever, the functional consequence of abnormal Notch signaling to meningiomas is unknown. Here, we report that
exogenous expression of the Notch pathway effector, HES1, is associated with tetraploid cells in meningioma cell
lines. Activated Notch1 and Notch2 receptors induced endogenous HES1 expression and were associated with
tetraploidy in meningiomas. Tetraploid meningioma cells exhibited nuclear features of chromosomal instability and
increased frequency of nuclear atypia, such as multipolar mitotic spindles and accumulation of cells with large
nuclei. FACS-sorted tetraploid cells are viable but have higher rates of spontaneous apoptosis when compared
with diploid cells. We have used spectral karyotyping to show that, in contrast to diploid cells, tetraploid cells
develop a higher number of both numerical and structural chromosomal abnormalities. Our findings identify a
novel function for the Notch signaling pathway in generating tetraploidy and contributing to chromosomal insta-
bility. We speculate that abnormal Notch signaling pathway is an initiating genetic mechanism for meningioma and
potentially promotes tumor development.
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Introduction
The Notch signaling pathway consists of Notch (Notch1–4 in mam-
mals), a family of transmembrane receptors, that undergo proteolytic
activation in response to ligand (Delta-like1,3,4 and Jagged1–2 in
mammals) binding to release the intracellular domain of Notch
[1]. The intracellular domain of Notch translocates to the nucleus
and acts as a transcriptional activator inducing the expression of
members of the HES (Hairy/Enhancer of Split) family of basic
helix–loop–helix transcriptional regulators [2]. HES proteins in turn
regulate the expression of downstream target genes [2].
Aberrant Notch signaling contributes to the genesis of diverse can-
cers. As the normal effect of Notch signaling during development dif-
fers from cell type to cell type, the tumorigenic effect of Notch is
varied and depends on the tissue in which the tumor develops [3].
Notch functions as an oncogene promoting tumorigenesis in tissues
where it normally functions to maintain stem cells or regulate pre-
cursor cell fates [4]. In T-cell leukemias, constitutively active Notch1
transforms cells in vitro [5] and cause mice to develop leukemia [6].
In contrast, Notch is a tumor suppressor in certain epithelial can-
cers where its normal function is to promote terminal differentiation
[4]. Mice with Notch1-deficient epithelia develop spontaneous basal
cell carcinoma–like tumors [7]. In yet other cancers, such as cervical
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cancers, the role of Notch is more complex. Notch signaling seems to
provide a permissive environment for the development of early lesions,
whereas progression to late-stage cervical lesions requires limiting
Notch signaling [8,9]. More recently, Notch has been shown to func-
tion as a regulator of pathologic angiogenesis in cancer. In head and
neck squamous cell carcinomas, activated Notch signaling in endo-
thelial cells promote neovascularization [10].
We have previously shown that the Notch signaling pathway is
deregulated in human meningioma tumors [11]. Over-expression
of Notch pathway components occurs with equal frequency in be-
nign and malignant meningiomas, suggesting that activation of this
pathway may be important for tumor initiation [11]. Meningiomas
are the most common primary brain tumor [12] and also develop in
half of all patients who suffer from neurofibromatosis 2 [13]. These
tumors are a considerable cause of morbidity and mortality because
of their location in the central nervous system. Meningiomas often
occur in difficult-to-access locations, and their continued growth im-
pacts surrounding brain tissue, causing serious neurologic deficits
[14,15]. In addition, 15% of meningiomas have malignant character-
istics, and these aggressive tumors are frequently fatal [16]. Menin-
giomas arise in the arachnoid layer of the meninges [17,18], and the
function of Notch signaling in the normal development of the
meninges is unknown. It is therefore difficult to predict the nature
of Notch function in meningioma tumor development.
The purpose of this study was to evaluate the functional conse-
quences of Notch signaling to meningioma tumor growth. We show
that exogenous expression of HES1 induces the formation of tetra-
ploid cells associated with features of chromosomal instability in
meningioma cells. Tetraploid meningioma cells have higher rates of
spontaneous apoptosis and an increased frequency of generation of
structural and numerical chromosomal abnormalities. Thus, aberrant
Notch signaling functions in regulating ploidy and enhancing chro-
mosomal instability in meningiomas.
Materials and Methods
Cell Lines
All human tissues were collected by the Neurological Surgery
Tissue Bank at the University of California, San Francisco (UCSF)
using protocols approved by the UCSF Committee on Human Re-
search. Human meningioma cell lines used were SF3061, SF4068,
and SF4433. The immortalization and characteristics of these cells
have been described earlier [19]. Briefly, SF3061, derived from a
malignant meningioma, has been immortalized by expression of
telomerase, whereas SF4068 and SF4433, derived from benign
meningiomas, have been immortalized by the expression of telome-
rase and the human papillomavirus E6/E7 genes. All three cell lines
were positive for vimentin and desmoplakin, characteristic markers
of meningiomas. These cell lines do not have increased Notch signal-
ing compared to normal arachnoidal cells and were therefore cho-
sen to exogenously express HES1. All cell lines were maintained in
Dulbecco’s modified Eagle’s medium supplemented with 10% fetal
bovine serum and appropriate antibiotic selection markers.
Expression Constructs
HES1 expression construct in pReceiver was obtained from
GeneCopoeia (Germantown, MD) and was transferred to the pLNCX2
retroviral vector using standard molecular biology techniques. Con-
structs of the activated intracellular domains of Notch1 (N1ICD)
and Notch2 (N2ICD) were kind gifts from Dr. Lucio Miele (Loyola
University, Chicago, IL) and Dr. Spyros Artavanis-Tsakonas (Harvard
Medical School, Boston, MA), respectively. These expression con-
structs were transferred to the pBABE-Neo retroviral vector using
standard molecular biology techniques. The HES1-promoter firefly
luciferase construct was a kind gift from Dr. Lucio Miele.
Retroviral Infection and Selection of Stable Cell Populations
Retroviral supernatants were produced by transfection of the Phoe-
nix A packaging cell line with retroviral plasmids using Lipofectamine
Plus Reagent (Invitrogen, Carlsbad, CA). The 48-hour posttransfection
supernatant was harvested and filtered, and polybrene (4 μg/ml) was
added and used to infect meningioma cell lines. Stable cell populations
were selected using 500 μg/ml of G418. In parallel, empty plasmids
were used to generate vector control stable cell lines.
Western Blot Analysis
The Notch1 (bTAN20) and Notch2 (C651.6DbHN) antibodies
developed by Spyros Artavanis-Tsakonas were obtained from the
Developmental Studies Hybridoma Bank (Iowa City, IA). The
HES1 antibody was a kind gift from Dr. Tetsuo Sudo (Toray Scien-
tific, Japan). The α-tubulin antibody was from Molecular Probes
(Eugene, OR). Cell lysates were prepared and Western blots were
performed as described earlier [11]. The molecular weights were de-
termined with the use of prestained protein ladders.
Immunofluorescence
Indirect immunofluorescence for HES1 and α-tubulin was per-
formed as described earlier [19]. Briefly, cells were fixed, permeabilized,
blocked, and sequentially incubated with primary and secondary
(4 μg/ml; Alexa 488 goat antirabbit IgG) antibodies. Cells were
mounted in DAPI mounting media, examined, and photographed with
a microscope (Zeiss, Thornwood, NY).
Flow Cytometry
Cells (70–80% confluent) were incubated with 1 mM bromo-
deoxyuridine (BrdU) for 1 hour at 37°C and processed using the
fluorescein isothiocyanate (FITC) BrdU Flow Kit (BD Biosciences,
San Diego, CA) following the manufacturer’s instructions. Briefly,
1 × 106 trypsinized cells were fixed, permeabilized, and digested with
DNAse. Cells were then stained with FITC-conjugated anti-BrdU
and 7-amino-actinomycin (7-AAD). Flow cytometry was performed
on a Becton Dickinson FACSCalibur machine. For each experiment,
10,000 events were counted. Data acquisition was performed with
the CellQuest software (BD Biosciences), and the percentages of
G1, S, and G2 phases of the diploid and tetraploid populations were
calculated with the MODFIT-LT software program (Verity Software
House, Topsham, ME). For the isolation of viable diploid and tetra-
ploid cells, cells (60–70% confluency) were incubated with 5 μg/ml of
Hoechst 33342 (Calbiochem, San Diego, CA) for 2 hours at 37°C, tryp-
sinized, and sorted using a Becton Dickinson FACS Vantage machine.
For evaluating the percentage of total cells that were apoptotic, the sub-
G0 population (apoptotic population) was calculated using CellQuest.
Promoter Assays
Cells grown in 24-well plates were transfected in triplicate with
1 μg of various plasmid constructs using Lipofectamine (Invitrogen).
The cells were cotransfected with 250 ng of pRL-CMV as a control
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for transfection efficiency. Forty-eight hours after transfection, the
firefly and Renilla luciferase activities were measured using the
Dual-Luciferase Reporter Assay System (Promega, Madison, WI) as
recommended by the manufacturer and a Sirius Luminometer
(Berthold Detection Systems, Oak Ridge, TN). Firefly luciferase activ-
ity was normalized to 5 × 106 Renilla luciferase activity units.
Spectral Karyotyping
SF3061-Vector and isolated SF3061-HES1 diploid and tetraploid
cells were analyzed at passages 8 and 19 after transfection with
HES1. Immortalized arachnoidal cells at similar passage numbers
were used as normal controls. Cells were incubated with 10 μg/ml
of colcemid for 2.5 hours, and metaphase chromosome spreads were
prepared as described earlier [20]. Human spectral karyotyping
(SKY) paint probes and the SKY kit were obtained from Applied
Spectral Imaging (Carlsbad, CA). In situ hybridization of the SKY
probes on the metaphase chromosome preparations were performed
following manufacturer’s instructions and as described previously
[20]. Briefly, the metaphase spreads were serially digested with pepsin,
denatured in formamide and hybridized to SKY probes. Chromosome-
specific fluorescence spectra were developed with combinations of the
rhodamine, Texas red, Cy5, Cy5.5, and FITC fluorochromes. Spectral
images were captured using a SD200 SpectraCube interferometer–
based spectral imaging system (Applied Spectral Imaging). Karyotypes
were analyzed using the SKYView software (version 1.62). Fifteen
metaphases were analyzed at each passage number for SF3061-Vector
and isolated SF3061-HES1 tetraploid cells, whereas eight metaphases
were analyzed for isolated SF3061-HES1 diploid cells.
Results
Exogenous Expression of HES1 Induces Tetraploidy
in Meningioma Cell Lines
Because HES1 is a primary downstream effector of Notch signal-
ing and is over-expressed in human meningioma tumors, we rea-
soned that HES1 was a good candidate to evaluate the functional
consequences of Notch signaling in meningiomas. Therefore, we
exogenously expressed HES1 in meningioma cell lines using retro-
viral mediated gene transfer. Expression and subcellular localization
of HES1 in stable cell populations was verified using Western blot
analysis (Figure 1A) and immunofluorescence (Figure 1B). Whereas
SF4068-Vector cells were negative for HES1, SF4068-HES1 cells
had strong nuclear staining in approximately 60% of the cells (Fig-
ure 1B). We evaluated the cell cycle position of individual SF4068-
Vector and SF4068-HES1 cells at passage 2 (post–G418 selection)
using immunofluorescence staining of incorporated BrdU and co-
staining for total DNA content with 7-AAD, followed by two-color
flow cytometric analysis. Expression of HES1 caused 68 to 75% of
the cells to double their total DNA content, i.e., they were tetraploid
(Figure 1C ). The relative percentage of cells in Diploid G0/1 and
Figure 1. Exogenous expression of HES1 is associated with tetraploidy in meningioma cell lines. HES1 was expressed in menin-
gioma cell lines using retroviral-mediated gene transfer. (A) Western blot analysis using a polyclonal antibody against HES1 in control
(lanes 1–3) and stable (lanes 4–6) cell populations. Lane 1, SF4068-Vector; lane 2, SF4433-Vector; lane 3, SF3061-Vector; lane 4, SF4068-
HES1; lane 5, SF4433-HES1; lane 6, SF3061-HES1. α-Tubulin was included as a loading control. (B) Immunofluorescence using the
HES1 polyclonal antibody (left panel) was used to show nuclear localization of HES1 in SF4068-HES1 stable cell populations. Nuclei
were counterstained with DAPI (right panel). Arrow indicates HES1-positive nucleus; arrowhead, HES1-negative nucleus. (C) Immuno-
fluorescent staining for incorporated BrdU and total DNA content by 7-AAD, followed by biparametric BrdU/7-AAD flow cytometric anal-
ysis was performed in Vector and HES1 stable cell populations. The BrdU fluorescence (y-axis) for SF4068-Vector and SF4068-HES1
cells is plotted against total DNA content (x-axis). (D) The number of individual cells (y-axis) for the indicated Vector or HES1 stable cell
populations is plotted against total DNA content (x-axis). The 2n, 4n, and 8n peaks are indicated above the plots.
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Diploid S in both the SF4068-Vector and SF4068-HES1 cells was
not altered, suggesting that HES1 did not alter the growth rate of
SF4068 cells. Similar results were obtained when HES1 was ex-
pressed in SF4433 and SF3061 meningioma cell lines (Figure 1D).
In all three cases, HES1 expression was associated with the appear-
ance of tetraploid cells.
HES1-Induced Tetraploidy Is Associated with Features
Indicative of Chromosomal Instability
Because tetraploidization is often an intermediate step in the process
to aneuploidy and enhanced aneuploidy is indicative of chromosomal
instability [21], we evaluated for features of chromosomal instability in
HES1 stable cells. SF4068-HES1 cells showed nuclear atypia charac-
terized by the presence of micronuclei, nuclear bridges, and elongated
and lobulated nuclei (Figure 2, A–E ), none of which were observed in
SF4068-Vector cells (Figure 2F ). Cells with nuclear atypia were typi-
cally positive for HES1 expression (Figure 2, G–L). We performed
immunofluorescence using an antibody against α-tubulin to view
mitotic spindle structures. SF4068-HES1 cells had an increased fre-
quency of aberrant mitotic spindle structures, including multipolar
spindles (Figure 2M–O), none of which were observed in control cells.
Both Activated Notch1 and Notch2 Induce Tetraploidy
in Meningiomas
Whereas HES1 is a primary target of Notch signaling, recent
studies have shown that other signaling pathways can regulate
Figure 2. Tetraploidy in meningioma is associated with features of chromosomal instability and mitotic spindle anomalies. DAPI staining
(blue stain) was used to show that SF4068-HES1 cells were associated with an increased frequency of nuclear atypia (A–E) characterized
by the presence of micronuclei (arrows), elongated and lobulated nuclei, and nuclear bridges (arrowhead), not found in SF4068-Vector
cells (F). Individual nuclei exhibiting atypia were HES1-positive (green stain; compare G–I with J–L). Staining with α-tubulin (red stain,
M–O) revealed aberrant mitotic spindles, including multipolar spindles (O) in SF4068-HES1 cells.
Neoplasia Vol. 10, No. 6, 2008 Notch Induced Tetraploidy in Meningiomas Baia et al. 607
HES1 expression in a Notch-independent fashion [22]. In addition,
different Notch receptor and ligand homologs can have different,
nonredundant and sometimes opposing functions [23,24]. We had
previously shown that meningiomas express both the Notch1 and
Notch2 proteins [11]. We therefore evaluated whether Notch1
and/or Notch2 could induce tetraploidy in SF4068 cells by exoge-
nously expressing the activated intracellular domains of Notch1
(N1ICD) and Notch2 (N2ICD; Figure 3A). Both SF4068-N1ICD
and SF4068-N2ICD stable cell populations induced HES1 promoter
activity (Figure 3B), and endogenous HES1 protein expression
(Figure 3C ) compared with SF4068-Vector cells. Both N1ICD and
N2ICD expression was associated with the appearance of tetraploid
cells in SF4068 (Figure 3D). Although the amplitude of induction
of HES1 promoter activity by N1ICD and N2ICD was different,
most cells in these stable cell populations were positive for nuclear
HES1, and there was no difference in the incidence of tetraploidy.
The N1ICD- and N2ICD-associated tetraploid cells exhibited fea-
tures of chromosomal instability (data not shown). Similar results
were obtained when N1ICD and N2ICD were exogenously ex-
pressed in SF4433 meningioma cells (data not shown). Thus, both
Notch1 and Notch2 receptor homologs have similar functions in
altering the ploidy of meningioma cells.
Tetraploid Cells Are Viable and Have Slightly Higher Rates
of Spontaneous Apoptosis
Tetraploid cells have different fates depending on the cell type and
the genetic context. In cell lines with an intact tetraploidy check-
point, they are cell cycle–arrested and eliminated, whereas in others,
Figure 3. Activated Notch1 and Notch2 induce endogenous HES1 expression and tetraploidy in meningioma cell lines. (A) Western blot
analysis of SF4068-Vector (V), SF4068-N1ICD (N1), and SF4068-N2ICD (N2) cells using monoclonal antibodies specific for Notch1 (n1) or
Notch2 (n2). α-Tubulin was included as a loading control. (B) Activity of the HES1 promoter was determined using the luciferase reporter
assay. Relative luciferase units (y-axis) in SF4068-Vector (V), SF4068-N1ICD (N1), and SF4068-N2ICD (N2) cells are plotted. (C) Immuno-
fluorescence using the HES1 polyclonal antibody (left panels) showed induction and nuclear localization of endogenous HES1 in SF4068-
N1ICD (N1) and SF4068-N2ICD (N2) stable cell populations. Nuclei were counterstained with DAPI (right panels). (D) Flow cytometric
analysis for total DNA content by 7-AAD was performed in SF4068-Vector (V), SF4068-N1ICD (N1), and SF4068-N2ICD (N2) cells. The
number of individual cells (y-axis) is plotted against total DNA content (x-axis). The 2n, 4n, and 8n peaks are indicated above the plots.
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stable propagation of tetraploid cells is observed. In addition, tetraploid
cells have altered apoptotic rates and response to apoptotic agents
when compared with their diploid counterparts [25]. To evaluate
whether tetraploid meningioma cells generated by expression of
HES1 were viable and not undergoing massive cell death, we sorted
the diploid G1 (2n) and tetraploid G2 (8n) populations and passaged
them separately in culture (Figure 4A). The ploidy of the tetraploid
cells was evaluated after 10 passages in culture. Greater than 90% of
the cells were still tetraploid (Figure 4B). Thus, the tetraploid cells
were viable and propagated stably. Next, we compared the apoptotic
rates of tetraploid cells to diploid cells. Whereas only 0.5% of the
SF4068-Vector diploid cells were spontaneously apoptotic, 4% of
the SF4068-HES1 tetraploid cells were spontaneously apoptotic
(Figure 4C ). Thus, tetraploid meningioma cells had slightly elevated
rates of spontaneous apoptosis.
Tetraploid Cells Acquire More Chromosomal Abnormalities
Compared to Diploid Cells
We used SKY to assess the frequency of generation of numerical
and structural chromosomal abnormalities in isolated SF3061-HES1
tetraploid cells compared with diploid cells. We chose SF3061 for
these experiments because SF4068 and SF4433 cells have been
immortalized with the E6/E7 oncogenes, which are known to
enhance genomic instability [26,27]. SKY analysis confirmed that
the tetraploid G2 (8n) population had double the DNA content of
SF3061-Vector cells (Figure 5A). The translocations present in
SF3061-Vector cells at P8 were considered baseline (Table 1 and
Figure 5). These metaphases contained 9.2 translocations per meta-
phase and an average of 42.8 chromosomes per metaphase. In con-
trast, tetraploid cells at the same passage had 19.3 translocations
per metaphase and an average of 89.3 chromosomes per metaphase
(Table 1). Thus, both the translocations per metaphase and number
of chromosomes per metaphase were slightly more than double in
the tetraploid cells when compared with the corresponding diploid
cells. In addition, tetraploid cells had acquired 23 translocations that
were not found in the corresponding diploid metaphases. After 11
further passages in culture, tetraploid cells had acquired an average
of 28.3 additional chromosomes per metaphase, whereas this number
was unchanged for the diploid cells (Table 1). Moreover, tetraploid
cells had acquired 137 total translocations, whereas diploid cells had
only acquired 3. As an additional control, we analyzed the trans-
locations in isolated SF3061-HES1 diploid cells at P19. Similar to
the SF3061-Vector metaphases, these diploid metaphases contained
8.9 translocations per metaphase and an average of 42.3 chromo-
somes per metaphase. Representative SKY karyograms of diploid
and tetraploid metaphase at P19 are shown in Figure 5. The tetra-
ploid metaphase contained several new translocations that were not
found in diploid metaphases such as t(2;10), t(6;4), t(10;3). In
addition, this metaphase had many numerical abnormalities such
as six copies of chromosome 4, 14, 16, 19, 21, and 22, six copies
of the t(3;8) translocation, and three copies of the t(17;20) and the
t(11;13) translocation. Thus, tetraploid cells generated by HES1 ex-
pression had a higher frequency of both numerical and structural
chromosomal abnormalities when compared with diploid cells, sug-
gesting that Notch signaling enhanced chromosomal instability in
meningioma cells.
Discussion
The contribution of aberrant Notch signaling to meningioma
tumorigenesis is unknown. We show that expression of activated
Notch1, Notch2, and HES1 induce tetraploidy associated with
features of chromosomal instability in meningioma cell lines. In
addition, we show that tetraploid cells exhibit chromosomal instabil-
ity developing a higher number of numerical and structural chromo-
somal aberrations.
Tetraploidy occurs commonly in many cancers and is often an
intermediate step in the process to aneuploidy, a hallmark of most
cancers and an end feature of chromosomal instability [28]. Usually,
cells with tetraploid DNA content arise as an early step in tumori-
genesis and precede the formation of aneuploid cells. This has been
Figure 4. Isolated tetraploid cells are viable but have higher spontaneous apoptotic rates compared with diploid cells. (A) Viable diploid
G1 (2n) cells were separated from tetraploid G2 (8n) cells using Hoechst Staining and flow cytometry and propagated in culture. (B) After
10 passages in culture, the ploidy of the tetraploid cells was measured by 7-AAD staining for total DNA content and flow cytometry. (C)
The percentage of apoptotic cells (y-axis) in SF4068-Vector (Vector) and isolated tetraploid cells from SF4068-HES1 (HES1-T) are shown.
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Figure 5. Tetraploid cells develop a higher number of numerical and structural chromosomal abnormalities over time in culture when
compared with diploid cells. Spectral karyotyping (SKY) was used to assess numerical and structural abnormalities in SF3061-Vector
and isolated diploid and tetraploid cells from SF3061-HES1 stable cell populations. (A) Representative SKY metaphases from control
nonneoplastic arachnoid (Arachnoid) cells, SF3061-Vector (Diploid), and SF3061-HES1 (Tetraploid) cells are shown. (B and C) SKY
karyograms of a diploid metaphase from SF3061-Vector cells at passage 19 (B) and a tetraploid metaphase from SF3061-HES1 cells
at passage 19 (C) are shown. Chromosome numbers (white) are indicated.
Table 1. Numerical and Structural Chromosomal Abnormalities in SF3061 Meningioma Cells.
Stable Cell Population Passage Number Number of Metaphases Analyzed Total Number of Translocations Translocations per Metaphase Mean Number of Chromosomes
per Metaphase
SF3061-Vector 8 15 138 9.2 42.8
SF3061-HES1 Tetraploid 8 15 289 19.3 89.3
SF3061-Vector 19 15 141 9.4 42.9
SF3061-HES1 Tetraploid 19 15 426 28.4 117.6
SF3061-HES1 Diploid 19 8 71 8.9 42.3
610 Notch Induced Tetraploidy in Meningiomas Baia et al. Neoplasia Vol. 10, No. 6, 2008
clearly demonstrated in Barrett esophagus, a premalignant condition
where patients are regularly followed by endoscopic biopsies [29,30].
A careful analysis of these patients has revealed the relatively early loss
of p53, the acquisition of a significant population of tetraploid cells,
and the subsequent development of aneuploidy. Also, in some tumor
models, such as the elastase–simian virus 40 tumor antigen transgenic
mouse model of pancreatic cancer, an increase in a tetraploid popula-
tion of cells is detected early in the development of tumor [31].
Tetraploid cells are normally cell cycle–arrested and undergo apop-
tosis if there is an intact tetraploidy checkpoint [32]. Also, a dis-
rupted p53 pathway has been proposed as being essential for the
survival of tetraploid cells [32]. In our study, tetraploid meningioma
cells associated with HES1 expression were viable albeit with a slightly
elevated apoptotic rate suggesting that the meningioma cell lines used
have a defective tetraploidy checkpoint. It is likely that any tetraploid
cells generated by transfecting HES1 in untransformed cells that have
robust cell cycle checkpoints would be eliminated.
In vivo, we anticipate that tetraploid meningioma cells without the
ability to evade apoptosis will die. Only cells with another cellular
defect such as a disrupted p53 pathway would survive. This could po-
tentially occur through a “prior genetic hit” that has provided a growth
advantage to the cell. A more likely scenario is that the genetically un-
stable tetraploid cell itself acquires a mutation or translocation that
provides a selective growth advantage allowing it to propagate.
Previous studies have shown that primary meningioma tumors con-
tain tetraploid cells and exhibit chromosomal instability. Fluorescence
in situ hybridization studies aimed at investigating chromosomal aber-
rations in meningiomas have frequently detected tetraploid cells [33–35].
One study, investigating chromosome 14q32 loss in 124 meningio-
mas, found tetraploid cells in 26% of meningiomas [33]. Using flow
cytometry, a hyperdiploid phenotype was observed in 30% (44/124
tumors) of meningioma cases analyzed [36]. In a separate study, spe-
cific features of chromosomal instability have also been found at high
frequency in meningiomas [37]. Early passage short-term primary
cultures from 61 meningiomas were analyzed and shown to have cells
with aberrant nuclear morphology including multinucleated cells,
anaphase bridges, chromatin strings and nuclear blebs [37]. Chromo-
somal aberrations including ring chromosomes, telomere associations,
and dicentric chromosomes were observed. A hyperdiploid karyotype
was found in 47.5% of these tumors. The authors concluded that
even slow-growing tumors such as meningiomas display chromosomal
instability [37]. Our studies suggest that deregulation of the Notch
signaling pathway is a potential mechanism that is responsible for
this phenotype.
Notch has previously been implicated in the control of ploidy
under certain cellular contexts. In the endocycle, DNA replication
is uncoupled from mitosis allowing cells to dramatically increase their
DNA content above diploid values. Drosophila follicle cells divide
mitotically and increase in number until mid-oogenesis when they
exit the mitotic cycle and enter the endocycle. The Notch signal-
ing pathway controls this mitotic/endocycle switch. Loss of Notch
or Delta results in the failure of these cells to form endocycles
[38,39]. Similarly, in humans, megakaryocytes are specialized pre-
cursors of platelets that are polyploid. The Notch signaling pathway
has been implicated in the generation of these polyploid mega-
karyocytes, although the mechanism of Notch function in this pro-
cess is not understood [40,41]. Finally, in Caenorhabditis elegans, a
gain of function mutation in glp1, an ortholog of Notch, prevents
primordial germ cells from making the mitosis to meiosis switch
(equivalent to twice the “normal” DNA content) and leads to the
overgrowth of primordial germ cells and the formation of germline
tumors [42]. In human germ cell tumors (seminomas and carcinoma
in situ), Notch2 and Notch4 are over-expressed, and it has been pro-
posed that deregulation of Notch causes dysfunction of the mitotic to
meiotic switch leading to abnormal chromosomal segregation and the
generation of aneuploid cells [43]. Thus, one of the many functions
of the Notch signaling pathway in certain cell types is the regulation
of ploidy. Our data show that meningiomas are one such cell type.
Tetraploidy can be induced by external signals or mutations that
result in either cell fusion or an abortive cell cycle including defects
in DNA replication, sister chromatid separation, mitotic spindle as-
sembly, mitotic checkpoint regulation, or cytokinesis [21,44]. The
aberrant expression of proteins regulating the G2/M phase transition
such as Aurora A, cyclin B1, forkhead transcription factor M3, and
mitotic spindle checkpoint proteins such as Bub and Mad have been
shown to induce tetraploidy [45,46]. It is possible the Notch signal-
ing induces tetraploidy by impacting expression of one or more of
these proteins. Understanding the mechanism by which Notch sig-
naling induces tetraploidy in meningiomas remains to be determined
and will be an important topic of future work.
In conclusion, our data identify a function for Notch signaling
in inducing chromosomal instability in meningiomas and potentially
contributing to meningioma tumorigenesis.
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